COSCIENS Biopharma (TSE:CSCI) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
COSCIENS Biopharma Inc., a biopharmaceutical company, has announced progress in its merger with Ceapro Inc., including management team changes and development of its product pipeline. The company is currently seeking a new President and CEO to guide future growth and is implementing cost reduction strategies, including staff cuts and program spend adjustments.
For further insights into TSE:CSCI stock, check out TipRanks’ Stock Analysis page.